133 related articles for article (PubMed ID: 23617262)
21. Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Ishihara K; Hangai M; Kita M; Yoshimura N
Ophthalmology; 2009 Sep; 116(9):1799-807. PubMed ID: 19643489
[TBL] [Abstract][Full Text] [Related]
22. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
[TBL] [Abstract][Full Text] [Related]
23. Vogt-Koyanagi-Harada syndrome (uveomeningoencephalitic syndrome).
Manethova K; Ernest J; Hrevus M
Eur J Ophthalmol; 2017 Jan; 27(1):e5-e8. PubMed ID: 28009404
[TBL] [Abstract][Full Text] [Related]
24. SS OCT and OCT-A Findings in Convalescent Inactive Vogt-Koyanagi-Harada Disease.
Ben Aoun S; Ksiaa I; Nefzi D; Khochtali S; Jelliti B; Abroug N; Khairallah M
Ocul Immunol Inflamm; 2024 May; 32(4):407-414. PubMed ID: 37948509
[TBL] [Abstract][Full Text] [Related]
25. Retinal vessel oxygen saturation is affected in uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Hardarson SH; Stefánsson E
Br J Ophthalmol; 2019 Dec; 103(12):1695-1699. PubMed ID: 30798260
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
[TBL] [Abstract][Full Text] [Related]
27. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
[TBL] [Abstract][Full Text] [Related]
28. Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease.
Hirooka K; Saito W; Namba K; Takemoto Y; Mizuuchi K; Uno T; Tagawa Y; Hashimoto Y; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):609-17. PubMed ID: 25619665
[TBL] [Abstract][Full Text] [Related]
29. Choroidal folds in acute Vogt-Koyanagi-Harada disease.
Zhao C; Zhang M; Wen X; Dong F; Han B; Du H
Ocul Immunol Inflamm; 2009; 17(4):282-8. PubMed ID: 19657984
[TBL] [Abstract][Full Text] [Related]
30. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Hirose S; Saito W; Yoshida K; Saito M; Dong Z; Namba K; Satoh H; Ohno S
Acta Ophthalmol; 2008 Dec; 86(8):902-7. PubMed ID: 19016661
[TBL] [Abstract][Full Text] [Related]
31. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
Maruko I; Iida T; Sugano Y; Oyamada H; Sekiryu T; Fujiwara T; Spaide RF
Retina; 2011 Mar; 31(3):510-7. PubMed ID: 20948460
[TBL] [Abstract][Full Text] [Related]
32. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
Lai TY; Chan RP; Chan CK; Lam DS
Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids.
Abu El-Asrar AM; Al Tamimi M; Hemachandran S; Al-Mezaine HS; Al-Muammar A; Kangave D
Acta Ophthalmol; 2013 Sep; 91(6):e486-93. PubMed ID: 23575246
[TBL] [Abstract][Full Text] [Related]
34. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
35. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease.
Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A
Retina; 2012; 32(10):2061-9. PubMed ID: 23095726
[TBL] [Abstract][Full Text] [Related]
36. Headache in late pregnancy: a symptom for Vogt-Koyanagi-Harada disease.
Matsubara S; Kuwata T; Ohkawara Y; Makino S
Arch Gynecol Obstet; 2011 Jun; 283(6):1423-5. PubMed ID: 21046128
[TBL] [Abstract][Full Text] [Related]
37. A case of Vogt-Koyanagi-Harada syndrome.
Hettler DL; Levinson JB
J Am Optom Assoc; 1992 Feb; 63(2):90-4. PubMed ID: 1583270
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Adalimumab for Chronic Vogt-Koyanagi-Harada Disease Refractory to Conventional Corticosteroids and Immunosuppressive Therapy and Complicated by Central Serous Chorioretinopathy.
Takayama K; Obata H; Takeuchi M
Ocul Immunol Inflamm; 2020 Apr; 28(3):509-512. PubMed ID: 31268769
[No Abstract] [Full Text] [Related]
39. A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab.
Su E; Oza VS; Latkany P
J Formos Med Assoc; 2019 May; 118(5):945-950. PubMed ID: 30616991
[TBL] [Abstract][Full Text] [Related]
40. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
Bouchenaki N; Morisod L; Herbort CP
Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]